Sung Won Lee

1.8k total citations
65 papers, 1.2k citations indexed

About

Sung Won Lee is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Sung Won Lee has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hepatology, 35 papers in Epidemiology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Sung Won Lee's work include Liver Disease Diagnosis and Treatment (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (25 papers) and Hepatitis C virus research (19 papers). Sung Won Lee is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (25 papers) and Hepatitis C virus research (19 papers). Sung Won Lee collaborates with scholars based in South Korea, United States and Japan. Sung Won Lee's co-authors include Seung Kew Yoon, Si Hyun Bae, Jeong Won Jang, Jung Hyun Kwon, Hae Lim Lee, Jong Young Choi, Soon Woo Nam, Sun Hong Yoo, Nam Ik Han and Pil Soo Sung and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Sung Won Lee

59 papers receiving 1.1k citations

Peers

Countries citing papers authored by Sung Won Lee

Since Specialization

Citations

This map shows the geographic impact of Sung Won Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung Won Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung Won Lee more than expected).

Fields of papers citing papers by Sung Won Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung Won Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung Won Lee. The network helps show where Sung Won Lee may publish in the future.

Co-authorship network of co-authors of Sung Won Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Sung Won Lee. A scholar is included among the top collaborators of Sung Won Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung Won Lee. Sung Won Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rifaximin treatment in patients with severe alcohol-associated hepatitis: A multicenter, randomized controlled, open-label, pilot trial 2024 ·Annals of Hepatology ·Do Seon Song, Jin Mo Yang, Young Kul Jung, Hyung Joon Yim, Hee Yeon Kim, Chang Wook Kim, Soon Sun Kim, Jae Youn Cheong, Hae Lim Lee, Sung Won Lee, Jeong‐Ju Yoo, Sang Gyune Kim, Young Seok Kim	0
2	A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization 2024 ·Frontiers in Oncology ·Hae Lim Lee, Seok‐Hwan Kim, Hee Yeon Kim, Sung Won Lee, Myeong Jun Song	3
3	Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study 2024 ·Frontiers in Oncology ·Ji Won Han, Pil Soo Sung, (unknown), (unknown), Soon Kyu Lee, Hyun Yang, Ji Hoon Kim, Heechul Nam, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Hyun Kwon, Chang Wook Kim, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Young Chul Yoon	0
4	Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality 2023 ·Alimentary Pharmacology & Therapeutics ·Sung Won Lee, Daniel Q. Huang, Ricki Bettencourt, Veeral Ajmera, Monica A. Tincopa, Nabil Noureddin, (unknown), Harris Siddiqi, Egbert Madamba, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Masato Yoneda, (unknown), Mesut Gümüşsoy, Diğdem Kuru Öz, Ayşe Erden, Rohit Loomba	6
5	Meta‐analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin 2023 ·Alimentary Pharmacology & Therapeutics ·Rebecca Wenling Zeng, Jie Ning Yong, Darren Jun Hao Tan, Clarissa Elysia Fu, Wen Hui Lim, Jieling Xiao, Kai En Chan, Caitlyn Tan, (unknown), Douglas Chee, Nicholas Syn, Eunice X. Tan, Mark Muthiah, Cheng Han Ng, Nobuharu Tamaki, Sung Won Lee, Beom Kyung Kim, Mindie H. Nguyen, Rohit Loomba, Daniel Q. Huang	52
6	A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance 2022 ·Journal of Hepatology ·Hyun Yang, Si Hyun Bae, Heechul Nam, Hae Lim Lee, Sung Won Lee, Sun Hong Yoo, Myeong Jun Song, Jung Hyun Kwon, Soon Woo Nam, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang	28
7	Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus 2021 ·Cancer Control ·Hae Lim Lee, Si Hyun Bae, Jaejun Lee, (unknown), Pil Soo Sung, Sung Won Lee, Jeong Won Jang, Jung‐Min Lee, Jong Young Choi, Nam Ik Han, Seung Kew Yoon	1
8	The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls 2021 ·Clinical and Molecular Hepatology ·Hae Lim Lee, Sung Won Lee	20
9	Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma 2021 ·Clinical and Molecular Hepatology ·Sung Won Lee, Jonggi Choi, Seung Up Kim, Young‐Suk Lim	31
10	PE-013 : Rifaximin Treatment in Patients with Severe Alcoholic Hepatitis; A Multicenter, Open-Label, Pilot Randomized Controlled Trial 2020 ·Do Seon Song, Jin Mo Yang, Young Kul Jung, Hyung Joon Yim, Hee Yeon Kim, Chang Wook Kim, Soon Sun Kim, Jae Youn Cheong, Hae Lim Lee, Sung Won Lee, Sang Gyune Kim, Young Seok Kim	1
11	Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis 2019 ·Gut ·Sung Won Lee, Jung Hyun Kwon, Hae Lim Lee, Sun Hong Yoo, Hee Chul Nam, Pil Soo Sung, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Nam Ik Han, Jeong Won Jang	96
12	Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization 2019 ·Scientific Reports ·Hae Lim Lee, Jeong Won Jang, Sung Won Lee, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Nam Ik Han, Seung Kew Yoon	138
13	Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression 2019 ·Scientific Reports ·(unknown), Jeong Won Jang, Sung Won Lee, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon	21
14	Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblasts of patients with rheumatoid arthritis 2019 ·Inflammopharmacology ·(unknown), Sang Yeob Lee, So Youn Park, Sung Won Lee, Ki Whan Hong, Chi Dae Kim	11
15	A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function 2017 ·Clinical and Molecular Hepatology ·Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, (unknown), Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, (unknown), Si Hyun Bae, Jong Young Choi, Seung Kew Yoon	28
16	On-treatment and off-treatment efficacy of entecavir in a real-life cohort of chronic hepatitis B patients 2016 ·European Journal of Gastroenterology & Hepatology ·Chung-Hwa Park, Hee Yeon Kim, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Hyun Kwon, Chan Ran You, Jeong Won Jang, Chang Wook Kim, Sang Wook Choi, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon	5
17	¹⁸F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study 2016 ·Journal of Nuclear Medicine ·Sae Jung Na, Jin Kyoung Oh, Seung Hyup Hyun, Jeong Won Lee, Il Ki Hong, Bong‐Il Song, Tae Sung Kim, Jae Seon Eo, Sung Won Lee, Ie Ryung Yoo, Yong An Chung, Mijin Yun	35
18	Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma 2015 ·PLoS ONE ·Jeong Won Jang, Young Woon Kim, Sung Won Lee, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Kyu Won Chung	25
19	MicroRNA-27a Modulates HCV Infection in Differentiated Hepatocyte-Like Cells from Adipose Tissue-Derived Mesenchymal Stem Cells 2014 ·PLoS ONE ·Jung Eun Choi, Wonhee Hur, Jung‐Hee Kim, (unknown), Eun Byul Lee, Sung Won Lee, Wonseok Kang, Eui‐Cheol Shin, Takaji Wakita, Seung Kew Yoon	13
20	Characteristics of epiretinal membranes according to the presence or absence of posterior vitreous detachment 2011 ·Eye ·Song Ee Chung, Ju Hee Lee, Se Woong Kang, Yun Taek Kim, Sung Won Lee	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact